Andrew Kaplan is named as a lobbyist on federal disclosure filings for 1 client through Takeda Pharmaceuticals America, Inc.. The most recent filing naming them posted in October 2026. Issues reported include Medicare/Medicaid, Health Issues, Budget/Appropriations and Taxation/Internal Revenue Code.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | TAKEDA PHARMACEUTICALS AMERICA, INC. | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Andrew Kaplan. See the Capitol Clarity rankings and method.